Related Experiment Videos
Interleukin-11. A gp130 cytokine
William L Trepicchio1, Andrew J Dorner1
1Department of Preclinical Molecular and Cellular Biology, Genetics Institute, Cambridge, Massachusetts 02140, USA.
Annals of the New York Academy of Sciences
|January 26, 1999
Summary
Interleukin-11 (IL-11) exhibits potent anti-inflammatory effects by inhibiting pro-inflammatory mediators in macrophages. This research clarifies IL-11
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Interleukin-11 (IL-11) is a gp130 family cytokine with overlapping signaling pathways with IL-6.
- Unlike IL-6, recombinant human IL-11 (rhIL-11) does not induce fever, suggesting distinct in vivo functions.
- IL-11 demonstrates significant anti-inflammatory activity in preclinical disease models.
Purpose of the Study:
- To investigate the anti-inflammatory mechanisms of rhIL-11.
- To compare the signal transduction pathways of IL-11 and IL-6.
- To elucidate differences in their effects on macrophage function.
Main Methods:
- Comparison of IL-11 and IL-6 effects on in vitro macrophage function.
- Analysis of pro-inflammatory mediator production (e.g., TNF-alpha, IL-12).
- Investigation of the role of NF-kappa B transcription factor inhibition.
Main Results:
- rhIL-11 reduces the production of pro-inflammatory mediators from activated macrophages.
- The anti-inflammatory effect of rhIL-11 is mediated at the transcriptional level via NF-kappa B inhibition.
- Distinct signaling pathways and functional outcomes between IL-11 and IL-6 were observed.
Conclusions:
- IL-11 possesses significant anti-inflammatory properties, distinct from IL-6.
- rhIL-11's mechanism involves transcriptional inhibition of pro-inflammatory cytokines via NF-kappa B.
- Further research into IL-11 and IL-6 signaling may reveal therapeutic differences.